SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-001897
Filing Date
2020-03-02
Accepted
2020-03-02 16:31:52
Documents
83
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20191231x10k248225.htm   iXBRL 10-K 2694456
2 EX-4.5 ex-4d5.htm EX-4.5 76728
3 EX-21.1 ex-21d1.htm EX-21.1 4933
4 EX-23.1 ex-23d1.htm EX-23.1 2994
5 EX-31.1 ex-31d1.htm EX-31.1 17162
6 EX-31.2 ex-31d2.htm EX-31.2 17943
7 EX-32.1 ex-32d1.htm EX-32.1 7982
8 EX-32.2 ex-32d2.htm EX-32.2 7359
9 GRAPHIC tmb-20191231x10k248225003.jpg GRAPHIC 45742
  Complete submission text file 0001558370-20-001897.txt   9591482

Data Files

Seq Description Document Type Size
10 EX-101.SCH tmb-20191231.xsd EX-101.SCH 63086
11 EX-101.CAL tmb-20191231_cal.xml EX-101.CAL 64026
12 EX-101.DEF tmb-20191231_def.xml EX-101.DEF 207078
13 EX-101.LAB tmb-20191231_lab.xml EX-101.LAB 546118
14 EX-101.PRE tmb-20191231_pre.xml EX-101.PRE 393629
85 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20191231x10k248225_htm.xml XML 1664655
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 20677318
SIC: 2834 Pharmaceutical Preparations